Development and Validation of a Physiology-based Model for the Prediction of Oral Absorption in Monkeys

By Willmann Stefan   Edginton Andrea   Dressman Jennifer  

Pharmaceutical Research, Vol. 24, Iss. 7, 2007-07 ,pp. : 1275-1282

Springer Publishing Company

Access to resources Recommend Favorite

Development of a Physiology-Based Whole-Body Population Model for Assessing the Influence of Individual Variability on the Pharmacokinetics of Drugs

By Willmann Stefan   Höhn Karsten   Edginton Andrea   Sevestre Michael   Solodenko Juri   Weiss Wolfgang   Lippert Jörg   Schmitt Walter  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 34, Iss. 3, 2007-06 ,pp. : 401-431

Springer Publishing Company

Access to resources Recommend Favorite

Steady-State Pharmacokinetics of Roflumilast and Roflumilast N -Oxide in Patients with Mild and Moderate Liver Cirrhosis

By Hermann Robert  

Clinical Pharmacokinetics, Vol. 46, Iss. 5, 2007-01 ,pp. : 403-416

Adis International

Access to resources Recommend Favorite

Alfentanil-Induced Miosis as a Surrogate Measure of Alfentanil Pharmacokinetics in Patients with Mild and Moderate Liver Cirrhosis

By Baririan Nariné   Luc Van Obbergh   Desager Jean-Pierre   Verbeeck Roger K.   Wallemacq Pierre   Starkel Peter   Horsmans Yves  

Clinical Pharmacokinetics, Vol. 46, Iss. 3, 2007-01 ,pp. : 261-270

Adis International

Access to resources Recommend Favorite

The Pharmacokinetics and Pharmacodynamics of Tolvaptan in Patients with Liver Cirrhosis with Insufficient Response to Conventional Diuretics: a Multicentre, Double-blind, Parallel-group, Phase III Study

By Sakaida I   Yanase M   Kobayashi Y   Yasutake T   Okada M   Okita K  

The Journal of International Medical Research, Vol. 40, Iss. 6, 2012-11 ,pp. : 2381-2393

Field House Publishing

Access to resources Recommend Favorite